In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico

被引:42
作者
Gonzalez, Roger [1 ]
Welsh, Oliverio [1 ]
Ocampo, Jorge [1 ]
Hinojosa-Robles, Rosa M. [2 ]
Vera-Cabrera, Lucio [1 ]
Delaney, Mary L. [3 ]
Gomez, Minerva [1 ]
机构
[1] Univ Hosp Dr Jose Eleuterio Gonzalez, Dept Dermatol, Monterrey, Mexico
[2] Univ Hosp Dr Jose Eleuterio Gonzalez, Dept Infect Dis, Monterrey, Mexico
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
关键词
ERYTHROMYCIN-RESISTANT PROPIONIBACTERIA; CUTANEOUS PROPIONIBACTERIA; RIBOSOMAL-RNA; VULGARIS; SKIN; SURVEILLANCE; ANTIBIOTICS; EUROPE;
D O I
10.1111/j.1365-4632.2010.04506.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Antimicrobials are essential in acne therapy. In the last decades, Propionibacterium acnes has become resistant to different antibiotics. Objective To determine antimicrobial susceptibility patterns of P. acnes to frequently used drugs. Materials and methods Cutaneous lesion samples were obtained from 50 patients with acne vulgaris, which were cultured in anaerobic media to demonstrate the presence of P. acnes. After that, antimicrobial susceptibility tests to tetracycline, minocycline, doxycycline, erythromycin, azithromycin, clindamycin, trimethoprim/sulfamethoxazole (SXT) and levofloxacin were performed. Results In the general study group, resistance to azithromycin was 82%, the most prevalent one (P < 0.05), followed by trimethoprim/sulfamethoxazole (68%) and erythromycin (46%). On the other hand, all strains isolated were susceptible to minocycline. Resistance bias were similar when subgroups with and without the previous antimicrobial therapy were performed, finding a low prevalence of resistance to tetracyclines and levofloxacin in both groups. Conclusions In our region, P. acnes is highly resistant to azithromycin, SXT, erythromycin and clindamycin; and being very susceptible to minocycline, levofloxacin and tetracycline, in vitro in both groups: with and without the previous antibiotic use. To our knowledge, high resistance prevalence to azithromycin and SXT has never been reported.
引用
收藏
页码:1003 / 1007
页数:5
相关论文
共 30 条
[1]   Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study [J].
Coates, P ;
Vyakrnam, S ;
Eady, EA ;
Jones, CE ;
Cove, JH ;
Cunliffe, WJ .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (05) :840-848
[2]  
Cunliffe WJ, 1999, BRIT J DERMATOL, V141, P757
[3]   ERYTHROMYCIN RESISTANT PROPIONIBACTERIA IN ANTIBIOTIC TREATED ACNE PATIENTS - ASSOCIATION WITH THERAPEUTIC FAILURE [J].
EADY, EA ;
COVE, JH ;
HOLLAND, KT ;
CUNLIFFE, WJ .
BRITISH JOURNAL OF DERMATOLOGY, 1989, 121 (01) :51-57
[4]   The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria [J].
Eady, EA ;
Bojar, RA ;
Jones, CE ;
Cove, JH ;
Holland, KT ;
Cunliffe, WJ .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (01) :107-113
[5]   Topical Antibiotics in Dermatology: Emerging Patterns of Resistance [J].
Elston, Dirk M. .
DERMATOLOGIC CLINICS, 2009, 27 (01) :25-+
[6]  
Espersen F, 1998, BRIT J DERMATOL, V139, P4
[7]  
Fluhr JW, 1999, ZBL BAKT-INT J MED M, V289, P53
[8]   Comparative in vitro activities of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P-acnes isolates [J].
Goldstein, EJC ;
Citron, DM ;
Merriam, CV ;
Warren, YA ;
Tyrrell, KL ;
Fernandez, HT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :379-381
[9]  
Gubelin Walter, 2006, Rev Latinoam Microbiol, V48, P14
[10]  
Hecht D, 2007, M11A7 CLSI, V27, P1